Logo image of CLGX

Corelogic (CLGX) Stock Fundamental Analysis

NYSE:CLGX - New York Stock Exchange, Inc. -

80  +0.47 (+0.59%)

After market: 79.98 -0.02 (-0.02%)

Fundamental Rating

1

Overall CLGX gets a fundamental rating of 1 out of 10. We evaluated CLGX against 81 industry peers in the Professional Services industry. CLGX has a bad profitability rating. Also its financial health evaluation is rather negative. CLGX is quite expensive at the moment. It does show a decent growth rate.


Dividend Valuation Growth Profitability Health

Quickly go to:

0

1. Profitability

1.1 Basic Checks

In the past year CLGX was profitable.

1.2 Ratios

Industry RankSector Rank
ROA 7.42%
ROE 42.47%
ROIC N/A
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A

1.3 Margins

Industry RankSector Rank
OM 21.1%
PM (TTM) 18.75%
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A

More info and screens

0

2. Health

2.1 Basic Checks

There is no outstanding debt for CLGX. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.

2.2 Solvency

CLGX has a Debt/Equity ratio of 2.33. This is a high value indicating a heavy dependency on external financing.
Industry RankSector Rank
Debt/Equity 2.33
Debt/FCF N/A
Altman-Z N/A
ROIC/WACCN/A
WACCN/A

2.3 Liquidity

Industry RankSector Rank
Current Ratio N/A
Quick Ratio N/A

More info and screens

4

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 55.84% over the past year.
The Earnings Per Share has been growing by 18.82% on average over the past years. This is quite good.
The Revenue has decreased by -4.26% in the past year.
The Revenue has been growing slightly by 1.45% on average over the past years.
EPS 1Y (TTM)55.84%
EPS 3Y24%
EPS 5Y18.82%
EPS Q2Q%57.89%
Revenue 1Y (TTM)-4.26%
Revenue growth 3Y-3.91%
Revenue growth 5Y1.45%
Sales Q2Q%-4.75%

3.2 Future

The Earnings Per Share is expected to grow by 0.99% on average over the next years.
The Revenue is expected to grow by 0.66% on average over the next years.
EPS Next Y-3.64%
EPS Next 2Y-2.44%
EPS Next 3Y0.51%
EPS Next 5Y0.99%
Revenue Next Year4.62%
Revenue Next 2Y1.56%
Revenue Next 3Y1.56%
Revenue Next 5Y0.66%

3.3 Evolution

When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
CLGX Yearly Revenue VS EstimatesCLGX Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 500M 1B 1.5B
CLGX Yearly EPS VS EstimatesCLGX Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 1 2 3 4

More info and screens

1

4. Valuation

4.1 Price/Earnings Ratio

Based on the Price/Earnings ratio of 16.19, the valuation of CLGX can be described as correct.
When comparing the Price/Earnings ratio of CLGX to the average of the S&P500 Index (29.62), we can say CLGX is valued slightly cheaper.
With a Price/Forward Earnings ratio of 18.68, CLGX is valued on the expensive side.
The average S&P500 Price/Forward Earnings ratio is at 22.70. CLGX is around the same levels.
Industry RankSector Rank
PE 16.19
Fwd PE 18.68
CLGX Price Earnings VS Forward Price EarningsCLGX Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 5 10 15 20 25

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA 13.51
CLGX Per share dataCLGX EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 5 10 15 20

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)0.86
EPS Next 2Y-2.44%
EPS Next 3Y0.51%

More info and screens

2

5. Dividend

5.1 Amount

With a Yearly Dividend Yield of 1.65%, CLGX has a reasonable but not impressive dividend return.
Compared to the average S&P500 Dividend Yield of 2.27, CLGX is paying slightly less dividend.
Industry RankSector Rank
Dividend Yield 1.65%

5.2 History

CLGX does not have a reliable dividend history as it only pays dividend since a couple or years.
Dividend Growth(5Y)N/A
Div Incr YearsN/A
Div Non Decr YearsN/A
CLGX Yearly Dividends per shareCLGX Yearly Dividends per shareYearly Dividends per share 2020 2021 0.2 0.4 0.6 0.8 1

5.3 Sustainability

28.80% of the earnings are spent on dividend by CLGX. This is a low number and sustainable payout ratio.
DP28.8%
EPS Next 2Y-2.44%
EPS Next 3Y0.51%
CLGX Dividend Payout.CLGX Dividend Payout, showing the Payout Ratio.CLGX Dividend Payout.PayoutRetained Earnings

More info and screens

Corelogic

NYSE:CLGX (6/3/2021, 8:12:16 PM)

After market: 79.98 -0.02 (-0.02%)

80

+0.47 (+0.59%)

Chartmill FA Rating
GICS SectorIndustrials
GICS IndustryGroupCommercial & Professional Services
GICS IndustryProfessional Services
Earnings (Last)N/A N/A
Earnings (Next)N/A N/A
Inst Owners0%
Inst Owner Change0%
Ins Owners1.02%
Ins Owner Change0%
Market Cap5.89B
Analysts60
Price Target79.13 (-1.09%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 1.65%
Yearly Dividend1.32
Dividend Growth(5Y)N/A
DP28.8%
Div Incr YearsN/A
Div Non Decr YearsN/A
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE 16.19
Fwd PE 18.68
P/S 3.44
P/FCF N/A
P/OCF N/A
P/B 7.79
P/tB N/A
EV/EBITDA 13.51
EPS(TTM)4.94
EY6.17%
EPS(NY)4.28
Fwd EY5.35%
FCF(TTM)N/A
FCFYN/A
OCF(TTM)N/A
OCFYN/A
SpS23.26
BVpS10.27
TBVpSN/A
PEG (NY)N/A
PEG (5Y)0.86
Profitability
Industry RankSector Rank
ROA 7.42%
ROE 42.47%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM 21.1%
PM (TTM) 18.75%
GM N/A
FCFM N/A
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3Y0%
ROICexcg growth 5Y0%
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score5
Asset Turnover0.4
Health
Industry RankSector Rank
Debt/Equity 2.33
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio N/A
Quick Ratio N/A
Altman-Z N/A
F-Score5
WACCN/A
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)55.84%
EPS 3Y24%
EPS 5Y18.82%
EPS Q2Q%57.89%
EPS Next Y-3.64%
EPS Next 2Y-2.44%
EPS Next 3Y0.51%
EPS Next 5Y0.99%
Revenue 1Y (TTM)-4.26%
Revenue growth 3Y-3.91%
Revenue growth 5Y1.45%
Sales Q2Q%-4.75%
Revenue Next Year4.62%
Revenue Next 2Y1.56%
Revenue Next 3Y1.56%
Revenue Next 5Y0.66%
EBIT growth 1YN/A
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1YN/A
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1YN/A
OCF growth 3YN/A
OCF growth 5YN/A